Luliconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Luliconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A22907
Buy Now

Luliconazole Prices June 2023

Product
Category Region Price
Luliconazole Pharma API USA 467208 USD/MT
Luliconazole Pharma API China 394731 USD/MT
Luliconazole Pharma API Germany 431145 USD/MT


The United States’ luliconazole price for Q2 2023 in June was 467208 USD/MT.

The price of methacrylic acid in China in Q2 2023 was 394731 USD/MT.

In Germany, methacrylic acid prices for Q2 of 2023 reached 431145 USD/MT.

Luliconazole Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Luliconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of luliconazole pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing luliconazole price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Luliconazole Price Trend

Luliconazole Market Analysis

The global luliconazole market size reached US$ 196.6 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 327.6 Million, at a projected CAGR of 5.80% during 2023-2032.

  • The increasing prevalence of fungal infections along with rising cases of immunocompromised patients making them susceptible to infection has encouraged the requirement of treatments based on luliconazole. This is supported by population aging as well as a higher frequency of chronic diseases that have been observed to impair immunity.  
  • Growing awareness of both infections and better testing procedures are helping to identify more cases of fungal infections. This leads to an increase in the demand for products like luliconazole as a medical treatment and hence propelling the growth of the market itself.
  • Ongoing developments in dermatology care and product innovations are contributing to better use of the topical antifungal drugs, which in turn is creating a positive market outlook.
  • Considerable growth in online pharmacies and e-commerce has also increased the market share of luliconazole. This trend is especially notable in areas where physical or physical brick-and-mortar pharmacies are not easily available.
  • Regulatory approval of new luliconazole formulations and indications in new markets support the market growth. The growing number of clinical trials and regulatory approvals that are required for the development of the potential therapeutic applications of luliconazole further fuels the market.    
  • Medical inflation in developing countries is also opening avenues for individuals to avail of more advanced treatments for fungal infections. This economic factor promotes the consumption of the advanced antifungal agents such as luliconazole.  
  • Pharmaceutical companies are increasingly engaging in strategic collaborations and partnerships to enhance their product portfolios and expand their market presence. Such alliances often focus on the development and distribution of effective antifungal treatments, such as luliconazole.   
  • Luliconazole market is growing in the emerging economies, especially in the APAC and Latin America regions. This increase is attributed to the rise in urbanization, better healthcare infrastructures, as well as growing awareness of fungal infection.
  • Major manufacturers are heavily investing on advertising, promoting product differences, and setting prices to gain market share.
  • Development of distinctive solutions, including a single-dose therapy and enhanced topical preparations are supporting the growth of the market.  
  • The integration of digital health tools, such as mobile apps for tracking treatment progress and adherence, is creating a positive market outlook as these tools help patients manage their treatment regimens effectively, thereby improving outcomes with luliconazole therapy.

Luliconazole News

The report covers the latest developments, updates, and trends impacting the global luliconazole market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in luliconazole production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.

Latest developments in the luliconazole industry:

  • On 13th March 2024, Sanofi India Limited and Emcure Pharmaceuticals announced exclusive distribution partnership to broaden reach of Sanofi’s Cardiovascular brands. Through this partnership, Emcure Pharmaceuticals distributes and promote Sanofi’s cardiovascular products, including brands like Cardace, Clexane, Lasix, and Lasilactone.
  • On 17th April 2023, ChemWerth announced a multimillion-dollar investment into further expanding its manufacturing partnerships in China and India, which will allow the company to further diversify its supply and portfolio, develop new generic APIs, mitigate the risk of supply chain disruptions, and position the company to meet the increasing global demand for generic pharmaceuticals.

Product Description

Luliconazole is a topical antifungal agent primarily used for the treatment of fungal infections on all skin surfaces. It works by inhibiting the synthesis of ergosterol in the fungal cell membrane leading to cell membrane disruption and killing of the fungi. It also offers high potency and ability to kill dermatophytes, yeasts, and molds which is an appropriate treatment for resistant and recurring infections.

Moreover, it needs a shorter course of therapy when compared to other antifungals, thus increasing their adherence. Luliconazole can come in creams and lotions with a certain application method depending on the type of infection. Its once-a-day dosing regimen further facilitates the use of the product by patients.

Regional Coverage

The report provides a detailed analysis of the luliconazole market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends.

Global Luliconazole Price

The report offers a holistic view of the global luliconazole pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

North America Luliconazole Price

The analysis of luliconazole prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on luliconazole prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Asia Pacific Luliconazole Price

The luliconazole pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed luliconazole prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Europe Luliconazole Price

European luliconazole prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed luliconazole price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy,  Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


Middle East and Africa Luliconazole Price

The report explores the luliconazole pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on luliconazole prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Latin America Luliconazole Price

The analysis of luliconazole prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Luliconazole
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year  
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of luliconazole pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting luliconazole price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the luliconazole industry. 

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Luliconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More